SB830 restructures Maryland’s handgun‑roster process. The bill gives the Attorney General primary authority to review and approve petitions to add a handgun to the State roster — including a required legal determination that the model is lawful under state and federal law — and it requires Maryland State Police (or an accredited lab they hire) to perform standardized safety and functionality testing before any handgun can be listed.
The Handgun Roster Board is recast as a procedural oversight body: it compiles and publishes the roster, monitors compliance, recommends fees, and coordinates with the Attorney General and State Police, but it may not place handguns on the roster or decide legal or technical questions. The bill also creates testing protocols, confidentiality rules for submitted materials, a timeline for re‑evaluating existing roster entries, and a framework for fees, reports, and appeals.
At a Glance
What It Does
The bill requires petitioners seeking roster placement to submit identifying information and an exemplar; the Attorney General then performs a legal review and issues a written determination. The Maryland State Police must conduct (or contract for) testing and deliver a written test report before a handgun may be added.
Who It Affects
Manufacturers and petitioning entities that want firearms listed on Maryland’s roster, licensed firearm dealers who sell rostered guns in state, the Maryland State Police and independent testing laboratories, and the Handgun Roster Board that will shift to oversight and administration duties.
Why It Matters
It replaces a largely administrative roster process with a two‑step legal and technical gate: legal clearance from the Attorney General plus objective testing from the State Police. That combination sets a higher technical and documentary bar for market entry in Maryland and creates new compliance costs and administrative roles for state agencies and private labs.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB830 changes who decides which handguns are authorized for sale in Maryland and builds a mandatory testing layer into the process. A petitioner still initiates a request but must now supply precise identifiers (serial number, manufacturer, model, caliber), an exemplar or manufacturer technical specifications, and any manufacturer representations.
The Attorney General (or their designee) conducts a legal review of the petition and accompanying materials, applying a non‑exclusive list of characteristics — concealability, reliability, detectability, sporting utility, and others — and issues a written determination explaining whether the handgun is lawful to place on the roster and, if denied, whether remediation is possible.
If the Attorney General requests testing, the Maryland State Police must perform it or contract with an accredited independent lab. Testing is performed on a specimen sourced under documented chain‑of‑custody rules and may be procured from commercial distribution to limit selection bias.
The bill specifies categories of testing (function, drop/impact, safety mechanisms, environmental/mechanical integrity) and requires the State Police or contracted lab to produce a written test report that identifies the specimen and ammunition, describes the test sequence, documents malfunctions and discharges, includes photo/video evidence, and issues a pass/fail result. A handgun that fails testing cannot be listed until it passes.The Board’s role is sharply narrowed.
It receives the Attorney General’s written determination solely to compile and maintain the roster and must update the roster promptly after receipt of a final determination. The Board may not on its own place guns on the roster or reach independent determinations about lawfulness or safety.
Instead it handles procedural oversight: auditing testing and chain‑of‑custody practices, publishing annual reports and recommended fee schedules, holding stakeholder briefings, and advising the Attorney General and State Police. The bill also requires the Attorney General to publish final determinations and legal analyses online, allows confidential designation of submitted materials under strict rules, sets limits on resubmission after failures, and requires the State Police to test existing roster firearms on a fixed schedule.
The Five Things You Need to Know
The Attorney General must issue a written legal determination (including supporting analysis and whether remediation is available) after reviewing petitioner materials; petitioners carry the burden of proof.
Testing protocol requires function testing (500 continuous rounds of commercial factory ammunition) plus drop/impact, safety mechanism evaluation, and environmental/mechanical integrity checks.
A specimen fails function testing if it experiences more than six malfunctions in the 500‑round sequence; any unintended discharge or mechanical failure during any test is an automatic fail.
If a handgun fails testing, the petitioner may remediate and seek a retest, but cannot refile the same petition for two years from the fail determination unless they document a material design or manufacturing change.
Maryland State Police must test all handguns currently listed on the roster by March 31, 2028, and the Board must update the roster within 15 days after receiving any final Attorney General determination.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Definitions and key terms
The bill expands definitions used across the subtitle: it explicitly names the Attorney General (or designee) as a party with statutory authority and introduces "exemplar" for the specimen or manufacturer‑provided sample used in technical inspection and comparison. This formalizes the evidentiary status of specimens and clarifies who may conduct legal actions under the new structure.
Attorney General legal review, petition requirements, confidentiality, and publication
This new section moves initial decision‑making authority to the Attorney General. Petitioners must submit identifying markings, an exemplar or technical specifications, manufacturer statements, and any other requested materials. The AG has a 45‑day baseline review window that is tolled for reasonable requests for additional information and may be extended for good cause. The AG must weigh enumerated characteristics (concealability, caliber, detectability, reliability, sporting utility) and issue a written determination that states whether the handgun is lawful for placement, explains the legal analysis, and identifies possible remediation if denied. The AG may designate submitted materials confidential; recipients with access must follow confidentiality, conflict‑of‑interest, and recusal rules. Final determinations and supporting legal analyses are to be published online, and petitioners have a 30‑day window to appeal an adverse final decision under existing administrative appeal procedures.
Testing: who does it, how, and reporting
The Attorney General may request that Maryland State Police conduct testing to determine safety and functionality. MSP can perform tests or contract with accredited independent labs; the AG reviews any contracting agreement. Testing is to be conducted on a single specimen under documented chain‑of‑custody, with the option for MSP to source specimens from commercial distribution centers to reduce pre‑test selection bias. Required testing includes at minimum a 500‑round uninterrupted function test, drop and impact tests across conditions and heights, evaluation of safety mechanisms, and environmental/mechanical integrity testing; the bill sets pass/fail thresholds and makes any unintended discharge an automatic failure. MSP or the contracted lab must produce a detailed written test report (specimen ID, ammunition, test sequence, malfunctions and discharges, photos/videos, and pass/fail conclusion). MSP may require additional specimens if product variability or anomalous results arise. If a specimen fails, the petitioner may remediate and request retesting, but a refile for the same handgun is barred for two years absent documented material changes. MSP must also test all guns already on the roster by March 31, 2028, and adopt implementing regulations addressing protocols, accreditation, chain‑of‑custody, retest limits, and fees.
Board’s procedural oversight role, reporting, and coordination
The Board’s statutory role is redefined: it compiles, publishes, and distributes the roster, but it may not place handguns, make legal or safety determinations, or overturn AG/MSP decisions. Within 15 days of receiving a final AG determination the Board must update the roster. The Board must annually recommend a fee schedule for petitions, processing, testing, and retesting (based on administrative and testing costs) and submit an annual report to the General Assembly summarizing petitions, determinations, and testing results. The Board is tasked with compliance monitoring, audits, stakeholder engagement, member orientation and annual training on the distinct authorities of the AG, MSP, and the Board, and access to legal counsel from the Attorney General. The Board can request additional testing if it identifies credible concerns but cannot order it itself; the Secretary decides whether to proceed.
Existing prohibitions and criminal penalties remain, enforcement tools preserved
The bill leaves in place the statutory prohibition on manufacturing or selling handguns not included on the roster and preserves circuit‑court injunctive authority and criminal penalties (felony exposure with specified imprisonment and fines). Practically, the new approvals and testing regime raise the compliance requirements manufacturers and dealers must meet before selling new models in Maryland, while enforcement provisions give the Secretary and courts tools to address violations.
This bill is one of many.
Codify tracks hundreds of bills on Justice across all five countries.
Explore Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Maryland consumers and public‑safety officials — the standardized testing and legal review aim to remove handguns with demonstrated safety or legal concerns from legal sale, improving expected baseline safety of rostered models.
- Manufacturers and petitioners who meet the standards — they gain a clearer, documented path to roster inclusion and public publication of final determinations that can reduce regulatory uncertainty once approval is obtained.
- The Attorney General and Maryland State Police — the statute centralizes legal and technical authority, giving those offices clear mandates and discretion to set legal standards and technical protocols, which can improve consistent decision‑making.
- Responsible dealers and distributors — the roster updates and publication requirements give dealers clearer notice about what models are lawful to sell in Maryland and when roster changes take effect.
- The Handgun Roster Board — while it loses decision authority, the Board gains a defined oversight and governance role (auditing, reporting, education) that can increase procedural transparency and system integrity.
Who Bears the Cost
- Manufacturers and petitioners — costs of producing exemplars, funding 500‑round tests or redesigns, retesting, potential two‑year market exclusion after a failure, and fees recommended by the Board and adopted by the AG/Secretary.
- Maryland State Police and contracted testing laboratories — increased operational workload, need to establish accreditation and chain‑of‑custody processes, and carry out mass testing of existing roster firearms by the statutory deadline.
- Small manufacturers and niche designers — the financial and time costs of testing and potential redesigns may be proportionally heavier, possibly limiting Maryland market access for smaller firms.
- The Attorney General’s office and Board administration — publishing determinations, managing confidentiality designations, reviewing contracts, and handling appeals will require staffing and legal resources beyond baseline duties.
- Dealers and distributors — short‑term inventory and supply disruptions if particular models fail testing or are reevaluated, and administrative costs tracking roster updates.
Key Issues
The Core Tension
The central tension is between improving public safety through rigorous, documented legal review and objective technical testing, and imposing technical, financial, and administrative barriers that can delay or block lawful firearms from entering the Maryland market — a trade‑off between safety and market access that the implementing regulations and resource allocations will decisively shape.
The bill balances legal review and technical testing but leaves several operational and policy tensions unresolved. Single‑specimen testing reduces cost and administrative burden but risks missing production variability; the statute permits additional specimens only upon suspicion of variability, which could allow product lines with intermittent defects to pass if sampling is unrepresentative.
MSP’s authority to source specimens from commercial channels mitigates selection bias, but implementing chain‑of‑custody procedures and vendor cooperation will be procedurally complex. The law requires accreditation standards and test protocols to be promulgated by regulation; those standards will determine how onerous testing is in practice and how reproducible results are across labs.
Confidentiality and transparency are in tension. The Attorney General may designate submission materials confidential, which protects trade secrets and manufacturer security considerations, but the statute also directs publication of final determinations and legal analyses.
Striking the balance in the regulations (what is redacted, what is published) will be consequential for public oversight, investigative journalism, and manufacturer IP protection. Finally, the two‑year restraint on refiling after a fail determination protects the testing system from endless resubmissions but could also freeze lawful products out of the Maryland market absent material redesign, with competitive and consumer‑choice implications.
Operationally, MSP and the AG will need budgeted staff and lab capacity to meet testing and publication deadlines; absent funding, timelines and statutory deadlines may be difficult to meet, inviting procedural disputes and litigation.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.